Participants:0–17 years · 18–64 years
Substances:Mixture Of Allergen Extracts Of Dermatophagoides Pteronyssinus And Dermatophagoides Farinae Polymerized With Glutaraldehyde

Contact Research Centre

Asthma

Recruiting

Registered drug

Study on Salbutamol and Ipratropium Bromide for Treating Moderate Asthma Attacks in Children

Registered drug

Spain

Participants:0–17 years
Substances:Ipratropium Bromide Monohydrate

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Registered drug

Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis

Registered drug

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Hidradenitis

Not yet recruiting

Investigational

Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Investigational

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Img-007

Contact Research Centre

Mite allergy

Not yet recruiting

Registered drug

Efficacy and safety of house dust mite allergoid (Dermatophagoides farinae, D. pteronyssinus, aluminium hydroxide) in people with moderate to severe house dust mite allergy

Registered drug

Spain

Participants:0–17 years · 18–64 years
Substances:Aluminium Hydroxide

Contact Research Centre

Find therapies in clinical trials near you

30 trials match your criteria

Eczema nummular

A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.

Chronic obstructive pulmonary disease

Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

Idiopathic pulmonary fibrosis

Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis

Dermatitis atopic

Study of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness

Dermatitis atopic

Effectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis

Major depression

Study on Esketamine and Aripiprazole with Antidepressants for Treatment-Resistant Depression in Elderly Patients

Mite allergy

Study on the Effectiveness and Safety of Beltavac for Patients with Allergic Rhinitis from House Dust Mites

Asthma

Study on Salbutamol and Ipratropium Bromide for Treating Moderate Asthma Attacks in Children

Dermatitis atopic

Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis

Hidradenitis

Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

Dermatitis atopic

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Mite allergy

Efficacy and safety of house dust mite allergoid (Dermatophagoides farinae, D. pteronyssinus, aluminium hydroxide) in people with moderate to severe house dust mite allergy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.